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Reaction Patterns of Natural Xenophile Antibodies in Human Sera With 
Pancreatic Islet Cells and Porcine Lymphocytes 
V. Eckstein, W. Muller-Ruchholtz, and K. Ulrichs 
THE INCREASING shortage of allogeneic donor or-gans for clinical transplantation has induced those 
working in this field to turn their attention to xenotrans-
plantation and suitable donor species. A species which is 
much favoured at present, and has been used in prelimi-
nary clinical trials, is the pig. J Among the needed organs, 
the isolated porcine pancreatic islet appears to have the 
most realistic chance of being xenografted, since this 
miniature organ, unlike kidney, heart, or liver, is nonvas-
cularized at the time of transplantation. This means that 
preformed natural xenophile antibodies (NXA), which 
bind primarily to vascular endothelial cells and cause 
hyperacute and acute xenograft rejection of vascularized 
organs, would be of minor relevance for the survival of the 
islet xenograft unless the same target antigens are also 
expressed on other cells. To investigate the reactivity of 
NXA with islet cells and their crossreactivity with Iym-
phocytes, sera from healthy persons and type I diabetic 
patients (insulin-dependent diabetes mellitus [IDDM]) 
were analyzed in indirect immunofluorescence, antibody 
absorption, and inhibition assays for: (a) their binding 
pattern with porcine pancreatic islet cells; (b) cytotoxicity; 
(c) target epitope distribution and specificity; and (d) 
possible cellular origin. In the case of IDDM patients, the 
term "NXA" may be misleading, inasmuch, as they very 
likely represent a mixture of natural and diabetes-depen-
dent crossreacting xenophile antibodies. 
MATERIALS AND METHODS 
Human Test Sera and Blood Cells 
Human sera were collected from 34 healthy persons and 50 lOOM 
patients. The sera were heat inactivated and diluted 1:2 with 
phosphate-buffered saline before use. Human peripheral blood 
Iymphocytes (PBL) were obtained by venipuncture, followed by 
density gradient centrifugation of the heparinized blood. Cells 
were harvested, washed and prepared according to standard 
procedures. 
Porcine Pancreatic Tissue and Blood Cells 
Pancreatic tissue from male and female pigs (9-month-old, 100 to 
110 kg dead weight) were obtained from a local abattoir, cut to 
pieces, snap frozen in liquid nitrogen, and used for the preparation 
of frozen tissue sections. Porcine peripheral blood cells, ie, 
Iymphocytesimonocytes and erythrocytes, were obtained by col-
lecting heparinized blood during the slaughtering process. Cell 
separation and preparation were carried out according to a stan-
dard protocol for human cells. 
Absorption of Human Sera with Porcine Blood Cells 
Selected human sera (healthy persons, lOOM patients) were 
absorbed 3 x with either porcine Iymphocytesimonocytes (500 f.LL 
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serum incubated with 107 cells, 30 minutes at room temperature, 
gentle shaking) or with erythrocytes (500 f.LL serum incubated 
with 500 f.LL erythrocytes). Exhaustive absorption was not in-
tended, since determining antibody specificity was the object of 
the investigation and not complete antibody elimination. 
Natural Xenophile Antibody Analysis 
Cryostat sections of porcine pancreas were incubated with the 
human sera (healthy persons, IDOM patients) for 45 minutes, 
washed, and further incubated with an FITC-conjugated goat 
antihuman immunoglobulin (Ig), anti-IgG, or anti-IgM antiserum 
(Oianova, Hamburg, Germany). The reactivity of human NXA 
was analyzed with a Zeiss ICM-405 fluorescence microscope. The 
intensity of NXA binding was graded as strongly positive (titer ~ 
1 :32), weakly positive (titer :5 1: 16), or no reactivity. 
Pancreatic Target Cell Types 
The fluorescence analysis of NXA binding on the porcine pan-
creas included vascular endothelial cells (VE), ductal epithelial 
cells (DE), macrophages (MO), endocrine cells (EN), and exo-
crine cells (EX). 
Preincubation of Human Serum NXA 
with Various Carbohydrates 
For the NXA-binding inhibition test, human sera (healthy per-
sons, lOOM patients) were preincubated (30 minutes room tem-
perature, voJlvol) with carbohydrate solutions before being used 
on porcine pancreas tissue sections. The following mono- and 
disaccharides were used in a concentration of 1.5, IS, and 150 
mmol: N-acetyl-mannosamine, melibiose, cellobiose, rhamnose, 
gentiobiose, lactose, mannose, and saccharose. 
Detection of Human Complement Deposition 
on Porcine Pancreas 
A FITC-coupled mouse monoclonal antibody against human 
complement factor C3 was used to detect whether human com-
plement factors in combination with human immunoglobulins 
(from lOOM sera) bind to porcine pancreas. In this test, a 
two-colour immunofluorescence was carried out and human Ig 
was detected by a goat antihuman-Ig-Cy3 (cyanine fluorochrome) 
antiserum (Dianova). 
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Table 1. Inhibition of NXA Binding by Serum Absorption with 
Porcine Blood Cells 
Porcine Pancreatic Target Cell 
Absofptlon Status VE,OE, MO EX EN 
lOOM serum unabsorbed 1:16 1 :2 1:64 
Absorbed 1 x with PBl 1 :8 1:2 1:64 
Absorbed 2x with PBl 1:8 1 :2 1:64 
Absorbed 3 x with PBl 1:4 1:2 1:64 
Absorbed 1 x with ERYTHR 1:8 1 :2 1:64 
Absorbed 2x with ERYTHR 1 :8 1 :2 1 :64 
Absorbed 3x with ERYTHR 1:4 1:2 1:64 
PBL: porcine peripheral blood Iymphocy!e; ERYTHR: porcine erythrocyte; VE: 
vascular endothelial ce"; DE: ductal epithelial cell; MO: macrophage; EX: exocrine 
tissue; EN: endOCrine tissue; lOOM serum: serum from a type I diabetic patient 
w~h particularly strong NXA reactivity toward porcine endocrine cells; this serum 
was representative of lour Similarly reacting lOOM sera; the absorption effect was 
tested in Indirect Immunofluorescence histology (titer). 
RESULTS 
Cytotoxic Effects of Human NXA on Porcine 
Pancreatic Tissue 
To test whether human NXA that showed binding speci-
ficity for porcine pancreatic islets2 can activate human 
complement, the deposition of human complement factor 
C3 was evaluated by two-colour immunofluorescence his-
tology using an anti-C3 monoclonal antibody (MAb). The 
results of this study, which is not documented in detail by 
figures, clearly indicate C3 deposition in the case of 
positive NXA binding. This deposition was seen on all islet 
target cells, including intraislet VE, and it was completely 
eliminated by heat inactivating the test serum. 
Inhibition of NXA Binding by Serum Absorption with 
Porcine Blood Cells 
The following test was carried out to evaluate a possible 
target epitope relationship on different porcine cells. An 
IDDM serum containing NXA against vascular and ductal 
epithelial cells, macrophages, and islet cells, was repeat-
edly absorbed with porcine lymphocytes/monocytes or 
erythrocytes prior to its evaluation in immunofluorescence 
histology. The results are documented in Table 1 and can 
be summarized as follows: (1) three serum absorptions 
with porcine PBL resulted in a stepwise reduction of NXA 
with specificity for vascular endothelial and ductal epithe-
lial cells and macrophages, but not in a reduction ofNXA 
with specificity for exocrine and endocrine cells; (2) the 
latter finding was also obtained after absorption with the 
second cell type, the porcine erythrocyte; and (3) this 
reaction pattern was seen not only with specially selected 
IDDM sera but also in islet-reactive sera from normal 
persons (data not shown). 
NXA Binding Inhibition by Serum Preincubation 
with Carbohydrates 
As an extension of earlier studies3 we wanted to evaluate 
whether carbohydrate structures are parts of the NXA 
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Table 2. NXA Binding Inhibition by Serum Preincubation 
with Carbohydrates 
Preincubation with 
Porcine Pancreatic Target Cell 
Carbohydrate (150 mmol) VE, DE, MO EX EN 
lOOM serum: no 1:32 1:2 1:32 
preincubation 
N-acelyl-mannosamine 1:32 1:2 1:32 
Melibiose 1:4 1:2 1:4 
Cellobiose 1:32 1:2 1:32 
Rhamnose 1 :32 1:2 1:32 
Gentiobiose 1:32 1:2 1:32 
lactose 1 :32 1:2 1 :32 
Mannose 1:32 1:2 1:32 
Saccharose 1 :32 1:2 1:32 
VE: vascular endothelial cell; DE: ductal epithelial cell; MO: macrophage; EX: 
exocrine tissue; EN: endocrine tissue; lOOM serum: serum lrom a type I diabetic 
patient with particularly strong NXA reactivity toward porcine endocrine ceUs; this 
serum was representative 01 lour similarly reacting lOOM sera; preincubation 
(vollvol) was performed with three carbohydrate concentrations: 1.5, 15, and 150 
mmol; the preincubatlon effect was tested in Indirect Immunofluorescence histol-
ogy (titer). Only the resuH with 150 mmol is documented above. 
target epitopes on islet cells. Therefore, human sera 
(IDDM patients, n = 4) were incubated with eight different 
mono- and disaccharides of varying concentrations prior to 
histological evaluation. The results are documented in 
Table 2 and can be summarized as follows: (1) of the eight 
carbohydrates tested, only melibiose was capable of re-
ducing NXA binding, as revealed by indirect immunoflu-
orescence histology; (2) reduction of NXA binding was 
seen on all target cells, including the endocrine islet cells; 
and (3) this reduction increased with increasing carbohy-
drate concentration (Table 2 documents the results for 150 
mmolonly). 
DISCUSSION 
So far the origin ofNXA in IDDM patients is very unclear. 
As already mentioned, they may represent a mixture of 
natural and diabetes-dependent crossreacting xenophile 
antibodies. This can be assumed from our previous obser-
vations that NXA from IDDM patients showed stronger 
binding to porcine endocrine islet cells than NXA from 
healthy persons. 2 Unless this conflict is solved, the term 
"NXA" must be handled with caution. 
The present study was a continuation of these previous 
attempts by our laboratory to analyze xenophile antibodies 
in the serum ofIDDM patients? It appeared to be of major 
interest because eight clinical fetal porcine preislet xe-
nografts have already been performed in IDDM patients 
during the past 2 years in Stockholm. 1 They may have 
failed because they were attacked by NXA and graft-
induced xenophile antibodies in particular, following mat-
uration of the preislet cells. Our finding that deposition of 
human complement factor C3 follows NXA binding ap-
pears to be an important hint at the cytotoxic potential of 
these antibodies. If so, antibody elimination prior to por-
cine islet transplantation should be attempted. Studies 
along this line, namely to eliminate NXA and to down-
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regulate their production by pharmacological manipula-
tion, are presently also being perlormed in our group.4-6 
Absorption of the IDDM serum with porcine lymphocytes/ 
monocytes and erythrocytes clearly indicated that differ-
ent target epitopes on different target cell types are recog-
nized by NXA. This is not surprising since NXA represent 
a pool of antibodies with different specificities.7 ,g Conse-
quently, and this should be pointed out for clinical appli-
cation, the peripheral porcine blood lymphocyte may 
substitute as a target cell for vascular endothelial cells, but 
not for endocrine islet cells in pretransplant NXA screen-
ing assays. 
As an extension of previous studies by our group, it was 
found that NXA showed binding specificity for carbohy-
drate structures, particularly for the disaccharide meli-
biose. 3 The experiments reported here were perlormed 
according to the original protocol using IDDM sera with 
strong anti-islet NXA reactivity. Inhibition of NXA bind-
ing by preincubation was incomplete, possibly due to 
residual NXA with specificity for: (a) other carbohydrates, 
which were not included in our study; or (b) glycoproteins, 
which are detectable on porcine endothelial cells.9 Our 
finding that melibiose is a powerlul NXA inhibitor has 
been confirmed in the meantime by other groups which 
used either melibiose or related carbohydrates with galac-
tose residues. IO•11 Generally, healthy persons showed an 
identical antibody reduction pattern, though with quanti-
999 
tative differences, depending on the amount of reactive 
antibodies. 
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